The 2024 International Conference on Alzheimer's Disease and Related Diseases will be held in Guangzhou
2024-07-16
The "2024 International Conference on Alzheimer's Disease and Related Diseases" co hosted by the (China) Alzheimer's Disease Prevention and Control Association and Guangzhou Pharmaceutical Group was held in Guangzhou from July 13th to 15th, 2024. This grand event has attracted top researchers, clinical doctors, and industry experts from around the world, aiming to share the latest research results, clinical research progress, and treatment strategies to address the global challenge of Alzheimer's disease. It is reported that this international academic conference covers multiple key areas, including public health policy, medical technology innovation, methodology for early prevention and early diagnosis, clinical application of new drugs, health management, as well as legal issues related to such diseases and the application of long-term care insurance. It provides a valuable communication platform for researchers, promotes international cooperation and knowledge sharing, and will be a huge driving force in improving the early prevention level of Alzheimer's disease, exploring the pathogenesis and causes, and increasing public awareness and attention to this disease. Zhang Hui, a first level inspector of the Elderly Health Department of the National Health Commission, said that Alzheimer's disease and related diseases have brought enormous pain to many families and elderly people, posing a great threat to social and economic development and the medical security system. To cope with the challenges brought by the rapidly growing aging population and related diseases, it is necessary for the national government, medical scientists, and the whole society to pay attention and take joint actions to raise the awareness of prevention among the whole population. Li Chuyuan, Secretary of the Party Committee and Chairman of Guangzhou Pharmaceutical Group, stated in his opening speech that Guangzhou Pharmaceutical Group continues to deepen its efforts in the field of Alzheimer's disease. As a top-level academic event that has been held for nine consecutive years, the conference brings together top scientists and researchers in this field. We sincerely hope that this conference can promote innovation and cooperation, and vigorously promote the development of scientific research and industry in this field. It is worth mentioning that in addition to conducting related scientific research and innovation and drug development, Guangzhou Pharmaceutical Group also actively carries out public welfare activities for the prevention and treatment of Alzheimer's disease. Baiyunshan and Huang Traditional Chinese Medicine Company, subsidiaries of Guangzhou Pharmaceutical Group, have successively released China's first micro film "Let Love Go Home" and documentary "Hand in Hand, Let Love Go Home" focusing on Alzheimer's disease, which have caused widespread social response. In 2014, they established the first national charity fund for the prevention and treatment of Alzheimer's disease - Baiyunshan Compound Danshen Charity Fund. They have launched volunteer service projects such as "Let Love Go Home", "Caring for Alzheimer's patients and distributing 'Anti Lost Yellow Bracelets'", and caring for families of Alzheimer's disease patients. Wang Jun, President of the Alzheimer's Disease Prevention and Control Association of China, stated that the conference will play a very important and positive role in addressing the severe challenges of China's aging population and related diseases. The conference received enthusiastic responses from experts and the public nationwide, sharing new theories and breakthroughs, while exploring how to accelerate research work and address urgent needs for early diagnosis, treatment, and care of these diseases. It is reported that in addition to the main venue, this academic conference also includes specialized seminars on imaging, clinical practice, traditional Chinese medicine, early scientific prevention, tackling Alzheimer's disease in Beijing, young scientists, biomarker applications, cognitive rehabilitation, and artificial intelligence applications. During the conference, renowned experts and scholars from the field at home and abroad will give keynote speeches and special reports, and carry out comprehensive exchanges. This not only plays a positive role in promoting the prevention and treatment of Alzheimer's disease in China, but also further strengthens the connections between countries and regions, and jointly promotes the healthy development of Alzheimer's disease prevention and treatment. In addition, during the opening ceremony of the conference, the Alzheimer's Disease Prevention and Control Association Lifetime Achievement Award Ceremony was held to recognize outstanding scientists who have made significant contributions to the discipline construction, association development, and improvement of human health in the field of Alzheimer's disease prevention and control. (New Society)
Edit：Lubaikang Responsible editor：Chenze
Source：chinanews.com
Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email：lwxsd@liaowanghn.com
Greater Bay Area
Recommended Reading Change it 
Home
